Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14356/2745Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Adhikari, Prabhat | - |
| dc.date.accessioned | 2025-10-09T08:36:17Z | - |
| dc.date.available | 2025-10-09T08:36:17Z | - |
| dc.date.issued | 2025-04-11 | - |
| dc.identifier.uri | https://hdl.handle.net/20.500.14356/2745 | - |
| dc.language.iso | en_US | en_US |
| dc.publisher | Center for American Medical Specialists (CAMS) Kathmandu, Nepal | en_US |
| dc.title | Avoid fluoroquinolones as empiric therapy, reserve for tuberculosis | en_US |
| dc.type | Presentation | en_US |
| Appears in Collections: | Day II, 11 April 2025; Parallel session IV, Hall A; Infectious Disease and Epidemic Preparedness (Chairs: prof. Dr. Jeevan B Sherchand and Dr. Ranjan Bhatt) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| AVOID FLUOROQUINOLONES AS EMPIRIC THERAPY, RESERVE FOR.pdf | presentation. | 1.07 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.